Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1461 to 1470 of 2417

TitleReference numberPublishedLast updated
Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancerTA876
Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinomaTA865
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancerTA724
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA716
Nivolumab with ipilimumab for untreated advanced renal cell carcinomaTA780
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesotheliomaTA818
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinomaTA857
Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and overTA950
Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedemaMIB144
Non-alcoholic fatty liver disease (NAFLD): assessment and managementNG49

Results per page

  1. 10
  2. 25
  3. 50
  4. All